Ukraine

BMI View: Although largely regressive, the impact of the government's move to limit medicine procurement to domestic production will be low, given the small scale of state drug expenditure... 2013-04-09

BMI View: Drugmakers in Emerging Europe must contend with import restrictions as countries including Russia and Ukraine attempt to develop their own nascent pharmaceutical sectors and... 2013-03-25

BMI View: Despite Ukraine's worsening macroeconomic outlook, consumers continued to spend on medicines in 2012, accelerating growth. While we forecast continued medium-term growth,... 2013-03-18

BMI View: Recent meetings between the Prime Minister and local producers suggest the Ukrainian state will intervene in the market to improve local companies' prospects at the expense... 2013-03-06

BMI View: The import licensing law N0 5038-VI will undoubtedly create severe drug shortages and the withdrawal of drug companies from Ukraine. We believe it will also exacerbate social... 2013-02-01

BMI View: We view this latest development as a worrying escalation given the tenuous political and economic outlook for Ukraine. The potential for abuse of compulsory licencing has... 2013-01-28

BMI View: Ukraine's favourable demographics and rising incomes make it a lucrative market for many international drugmakers. Continued headline growth in dollar terms and strong long-term... 2012-11-14